Data from Japanese and American Pharmaceutical companies show how a new drug can significantly slow down cognitive decline in some patients, by 27 percent.
The 18-month trial involved nearly 2-thousand participants, who were in the early stages of the illness.
Dementia costs are more than a trillion dollars globally and early detection is crucial for recognising signs of Alzheimer's or other cognitive decline.
So, what will be the impact of this new drug?

Presenter: Mohammed Jamjoom

Guests:
Graeme Sutherland - Son of Alzheimer's sufferer & Social Media Ambassador for Alzheimer Scotland.

Bart De Strooper - Director of the UK Dementia Institute.

Susan Kohlhaas - Director of Research at Alzheimer's Research UK.

- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter:   / ajenglish  
- Find us on Facebook:   / aljazeera  
- Check our website: https://www.aljazeera.com/

@AljazeeraEnglish
#Aljazeeraenglish
#News
#InsideStory
#Alzheimer
#Japan
#UnitedStates
#US